Induction of CYP2A6 by rifampicin, phenobarbital and nicotine involves a glucocorticoid receptor-dependent mechanism

被引：0
|
作者：
Kirby, G
Maurel, P
Vilarem, MJ
机构：
[1] Univ Guelph, Ontario Vet Coll, Guelph, ON N1G 2W1, Canada
[2] INSERM, U128, Montpellier, France
来源：
FASEB JOURNAL | 2004年 / 18卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A994 / A994
页数：1
相关论文
共 50 条
  • [41] Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes
    Yamazaki, H
    Inoue, K
    Hashimoto, M
    Shimada, T
    [J]. ARCHIVES OF TOXICOLOGY, 1999, 73 (02) : 65 - 70
  • [42] Glucocorticoid receptor is indispensable for mineralocorticoid receptor-dependent induction of colonic epithelial Na plus channels
    Bergann, Theresa
    Fromm, Anja
    Borden, Steffen A.
    Fromm, Michael
    Schulzke, Joerg D.
    [J]. FASEB JOURNAL, 2011, 25
  • [43] Association of smoking with cadmium induction of hepatic CYP2A6 in humans
    Satarug, Soisungwan
    Moore, Michael R.
    [J]. TOXICOLOGY LETTERS, 2006, 164 : S284 - S284
  • [44] Characterization of the novel CYP2A6*21 allele using in vivo nicotine kinetics
    Nael Al Koudsi
    Jill C. Mwenifumbo
    Edward M. Sellers
    Neal L. Benowitz
    Gary E. Swan
    Rachel F. Tyndale
    [J]. European Journal of Clinical Pharmacology, 2006, 62 : 481 - 484
  • [45] Identification of novel CYP2A6*1B variants:: The CYP2A6*1B allele is associated with faster in vivo nicotine metabolism
    Mwenifumbo, J. C.
    Lessov-Schlaggar, C. N.
    Zhou, Q.
    Kranow, R. E.
    Swan, G. E.
    Benowitz, N. L.
    Tyndale, R. F.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (01) : 115 - 121
  • [46] CYP2A6 slow nicotine metabolism is associated with increased quitting by adolescent smokers
    Chenoweth, Meghan J.
    O'Loughlin, Jennifer
    Sylvestre, Marie-Pierre
    Tyndale, Rachel F.
    [J]. PHARMACOGENETICS AND GENOMICS, 2013, 23 (04): : 232 - 235
  • [47] Coumarin inhibits CYP2A6 and nicotine (NIC) metabolism in vitro but not in vivo.
    Tyndale, RF
    Kaplan, HL
    Zhang, W
    Sellers, EM
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 166 - 166
  • [48] Isoflavones inhibit nicotine C-oxidation catalyzed by human CYP2A6
    Nakajima, M
    Itoh, M
    Yamanaka, H
    Fukami, T
    Tokudome, S
    Yamamoto, Y
    Yamamoto, H
    Yokoi, T
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (03): : 337 - 344
  • [49] CYP2A6 and CYP2B6 are involved in nornicotine formation from nicotine in humans: Interindividual differences in these contributions
    Yamanaka, H
    Nakajima, M
    Fukami, T
    Sakai, H
    Nakamura, A
    Katoh, M
    Takamiya, M
    Aoki, Y
    Yokoi, T
    [J]. DRUG METABOLISM AND DISPOSITION, 2005, 33 (12) : 1811 - 1818
  • [50] Characterization of the novel CYP2A6*21 allele using in vivo nicotine kinetics
    Al Koudsi, Nael
    Mwenifumbo, Jill C.
    Sellers, Edward M.
    Benowitz, Neal L.
    Swan, Gary E.
    Tyndale, Rachel F.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (06) : 481 - 484
12345